Ascletis Pharma Dividends and Buybacks
Dividend criteria checks 0/6
Ascletis Pharma does not have a record of paying a dividend.
Key information
n/a
Dividend yield
5.2%
Buyback Yield
| Total Shareholder Yield | 5.2% |
| Future Dividend Yield | 0% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Is Ascletis Pharma (HKG:1672) In A Good Position To Deliver On Growth Plans?
Oct 07
We're Not Very Worried About Ascletis Pharma's (HKG:1672) Cash Burn Rate
Dec 19We're Hopeful That Ascletis Pharma (HKG:1672) Will Use Its Cash Wisely
Aug 23What You Need To Know About The Ascletis Pharma Inc. (HKG:1672) Analyst Downgrade Today
Nov 03Companies Like Ascletis Pharma (HKG:1672) Can Afford To Invest In Growth
Oct 13Need To Know: Analysts Just Made A Substantial Cut To Their Ascletis Pharma Inc. (HKG:1672) Estimates
Aug 24Here's Why We're Not Too Worried About Ascletis Pharma's (HKG:1672) Cash Burn Situation
May 19Ascletis Pharma Inc.'s (HKG:1672) Sole Analyst Just Made A Dazzling Upgrade To Their Forecasts
Mar 27We're Hopeful That Ascletis Pharma (HKG:1672) Will Use Its Cash Wisely
Feb 08Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if 1672's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 1672's dividend payments have been increasing.
Dividend Yield vs Market
| Ascletis Pharma Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (1672) | n/a |
| Market Bottom 25% (HK) | 3.3% |
| Market Top 25% (HK) | 8.1% |
| Industry Average (Biotechs) | 1.1% |
| Analyst forecast (1672) (up to 3 years) | 0% |
Notable Dividend: Unable to evaluate 1672's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 1672's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate 1672's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as 1672 has not reported any payouts.